Alterations in glutamatergic signaling in the brain of dopamine supersensitivity psychosis and non-supersensitivity psychosis model rats
- PMID: 28744562
- DOI: 10.1007/s00213-017-4695-5
Alterations in glutamatergic signaling in the brain of dopamine supersensitivity psychosis and non-supersensitivity psychosis model rats
Abstract
Background: The long-term administration of antipsychotics is known to induce dopamine supersensitivity psychosis (DSP). Although the mechanism of DSP involves mainly a compensatory upregulation of dopamine D2 receptors, the precise mechanisms underlying DSP are unknown. It is known that glutamatergic signaling plays a key role in psychosis. We thus conducted this study to investigate whether glutamatergic signaling plays a role in the development of DSP.
Methods: Haloperidol (0.75 mg/kg/day for 14 days) or vehicle was administered to rats via osmotic mini-pump. Haloperidol-treated rats were divided into groups of DSP rats and non-DSP rats based on locomotion data. Tissue levels of glutamate, glutamine, glycine, L-serine, D-serine, and GABA and the protein expressions of N-methyl-D-aspartate receptors (NMDAR), glutamic acid decarboxylase (GAD), and serine hydroxymethyltransferase (SHMT) in the rat brain regions were examined.
Results: In the DSP rats, the ratio of GABA to glutamate was significantly increased. In addition, the ratio of L-serine to glycine was increased. The striatal expressions of GAD and SHMT2 in the DSP rats were significantly increased. In contrast, the striatal expression of NMDAR2B in the non-DSP rats was significantly decreased.
Conclusions: The present study suggests that glutamatergic signaling is relatively decreased to GABA in DSP rats. Our results also showed that excessive doses of haloperidol can induce striatal NMDAR hypofunction in non-DSP rats, which could prevent the formation of tardive dyskinesia but cause treatment resistance. In view of the need for therapeutic strategies for treatment-resistant schizophrenia, further research exploring our present findings is necessary.
Keywords: Antipsychotic; Dopamine D2 receptor (DRD2); Glutamate; Glutamic acid decarboxylase (GAD); N-methyl-D-aspartate receptors (NMDARs); Serine hydroxymethyltransferase (SHMT); Striatum.
Similar articles
-
Upregulation of heat-shock protein HSP-70 and glutamate transporter-1/glutamine synthetase in the striatum and hippocampus in haloperidol-induced dopamine-supersensitivity-state rats.Pharmacol Biochem Behav. 2021 Dec;211:173288. doi: 10.1016/j.pbb.2021.173288. Epub 2021 Oct 13. Pharmacol Biochem Behav. 2021. PMID: 34653399
-
G protein-coupled receptor kinase 6/β-arrestin 2 system in a rat model of dopamine supersensitivity psychosis.J Psychopharmacol. 2015 Dec;29(12):1308-13. doi: 10.1177/0269881115593903. Epub 2015 Jul 14. J Psychopharmacol. 2015. PMID: 26174132
-
Reduction of dopamine and glycogen synthase kinase-3 signaling in rat striatum after continuous administration of haloperidol.Pharmacol Biochem Behav. 2021 Mar;202:173114. doi: 10.1016/j.pbb.2021.173114. Epub 2021 Jan 22. Pharmacol Biochem Behav. 2021. PMID: 33485878
-
GAD(67): the link between the GABA-deficit hypothesis and the dopaminergic- and glutamatergic theories of psychosis.J Neural Transm (Vienna). 2003 Jul;110(7):803-12. doi: 10.1007/s00702-003-0826-8. J Neural Transm (Vienna). 2003. PMID: 12811640 Review.
-
Alterations of Dopamine D2 Receptors and Related Receptor-Interacting Proteins in Schizophrenia: The Pivotal Position of Dopamine Supersensitivity Psychosis in Treatment-Resistant Schizophrenia.Int J Mol Sci. 2015 Dec 17;16(12):30144-63. doi: 10.3390/ijms161226228. Int J Mol Sci. 2015. PMID: 26694375 Free PMC article. Review.
Cited by
-
The Underlying Neurobiological Mechanisms of Psychosis: Focus on Neurotransmission Dysregulation, Neuroinflammation, Oxidative Stress, and Mitochondrial Dysfunction.Antioxidants (Basel). 2024 Jun 12;13(6):709. doi: 10.3390/antiox13060709. Antioxidants (Basel). 2024. PMID: 38929148 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous